Titlebook: Emerging Therapeutic Targets in Ovarian Cancer; Stan Kaye,Robert Brown,Martin Gore Book 2011 Springer Science+Business Media, LLC 2011

legacy

大洪水

Effects of Radiation Exposures,dies, folate-conjugated drug carriers and imaging agents. The preclinical and emerging clinical data demonstrate that the α-FR is an important therapeutic target in cancer with particular relevance in non-mucinous ovarian carcinoma.

Scleroderma

Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs,y advances in both surgical and chemotherapeutic strategies. In this introductory chapter, we summarise the existing treatments for epithelial ovarian cancer, introduce recent advances, and highlight unmet needs in the treatment of epithelial ovarian cancer.

LIMN

Novel Anti-angiogenic Therapies in Ovarian Cancer, focuses on the emergent data of new anti-angiogenic therapies in advanced ovarian cancer. We describe the developments to date, ongoing pivotal studies and critically appraise the role of novel anti-angiogenics in the treatment of ovarian cancer.

ORE

MEET

节约

Intrepid

遣返回国

Eosinophils

Targeting the AKT Pathway in Ovarian Cancer,abolism and survival. In ovarian cancer, alterations have been observed in both the catalytic and regulatory subunits of the PI3K enzyme, in the opposing phosphatase PTEN and in each of the three isoforms of AKT itself. The net effect is a frequent hyperactivation of the pathway which has been linke